Classifying hypopneas as obstructive or central can enhance transvenous phrenic nerve stimulation therapy patient selection and outcomes

20251 citationsJournal Articlehybrid Open Access

Authors

Kara Dupuy-McCauley · Mayo Clinic

Alan R. Schwartz · Universidad Peruana Cayetano Heredia

Shahrokh Javaheri · Bethesda North Hospital

Robin Germany · Minnesota Zoo

Scott McKane · Minnesota Zoo

Timothy I. Morgenthaler · Mayo Clinic

Abstract

Dupuy-McCauley K, Schwartz AR, Javaheri S, Germany R, McKane S, Morgenthaler TI. Classifying hypopneas as obstructive or central can enhance transvenous phrenic nerve stimulation therapy patient selection and outcomes. <i>J Clin Sleep Med</i>. 2025;21(12):2113-2120.

Topics & Keywords

Gastroesophageal reflux and treatments Dysphagia Assessment and Management Airway Management and Intubation Techniques

Publication Details

Published in: Journal of Clinical Sleep Medicine

Volume 21, Issue 12, pp. 2113-2120

DOI: 10.5664/jcsm.11904

Field-Weighted Citation Impact: 2.06

Command Palette

Classifying hypopneas as obstructive or central can enhance transvenous phrenic nerve stimulation therapy patient selection and outcomes

Authors

Abstract

Topics & Keywords

Publication Details